In one study (in 177 BC patients with a positive family history for BC and without BRCA1 and BRCA2 mutations), an association was found between a polymorphism in intron 4 of the PTEN gene and a lower age of diagnosis of BC (42.7 versus 48.1 years) [46]. This evidence concerns the gene BRCA2 and breast cancer.